Evidence map›Paper›PMID 33869067›Full record

ReviewFrontiers in oncology2021

Nanomaterial Complexes Enriched With Natural Compounds Used in Cancer Therapies: A Perspective for Clinical Application.

María Zenaida Saavedra-Leos, Euclides Jordan-Alejandre, César López-Camarillo, Amaury Pozos-Guillen, César Leyva-Porras, Macrina Beatriz Silva-Cázares

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

María Zenaida Saavedra-LeosCoordinación Académica Región Altiplano, Universidad Autónoma de San Luis Potosí, Matehuala, Mexico.
Euclides Jordan-AlejandrePosgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Mexico City, Mexico.
César López-CamarilloPosgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Mexico City, Mexico.
Amaury Pozos-GuillenLaboratorio de Ciencias Básicas, Facultad de Estomatología, Universidad Autónoma de San Luis Potosí, San Luis Potosi, Mexico.
César Leyva-PorrasLaboratorio Nacional de Nanotecnología, Centro de Investigación en Materiales Avanzados S.C. (CIMAV), Chihuahua, Mexico.
Macrina Beatriz Silva-CázaresCoordinación Académica Región Altiplano, Universidad Autónoma de San Luis Potosí, Matehuala, Mexico.
Autonomous University of San Luis Potosí · MXUniversidad Autónoma de la Ciudad de México · MXCentro de Investigación en Materiales Avanzados · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol and quercetin are natural compounds contained in many foods and beverages. Reports indicate implications for the health of the general population; on the other hand the use of both compounds has interesting results for the treatment of many diseases as cardiovascular affections, diabetes, Alzheimer's disease, viral and bacterial infections among others. Based on their capacities described as anti-inflammatory, antioxidant, and anti-aging, resveratrol and quercetin showed antiproliferative and anticancer activity specifically in maligned cells. These molecular characteristics trigger the pharmacological repurposing of both compounds and improved its research for treating different cancer types with interesting results at

Indexed as

cancernanomaterialspharmacological repurposingquercetinresveratrol

Identifiers

PMID33869067
PMCPMC8047625
OpenAlexW3140486387

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.